AU7203687A - Method of assay of inhibin - Google Patents

Method of assay of inhibin

Info

Publication number
AU7203687A
AU7203687A AU72036/87A AU7203687A AU7203687A AU 7203687 A AU7203687 A AU 7203687A AU 72036/87 A AU72036/87 A AU 72036/87A AU 7203687 A AU7203687 A AU 7203687A AU 7203687 A AU7203687 A AU 7203687A
Authority
AU
Australia
Prior art keywords
inhibin
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU72036/87A
Other versions
AU599373B2 (en
Inventor
David Morritz De Kretser
Robert Ian Mclachlan
David Mark Robertson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash Medical Centre
St Vincents Institute of Medical Research
Inhibin Pty Ltd
Monash University
Original Assignee
Monash Medical Centre
St Vincents Institute of Medical Research
Monash University
Biotechnology Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monash Medical Centre, St Vincents Institute of Medical Research, Monash University, Biotechnology Australia Pty Ltd filed Critical Monash Medical Centre
Publication of AU7203687A publication Critical patent/AU7203687A/en
Application granted granted Critical
Publication of AU599373B2 publication Critical patent/AU599373B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU72036/87A 1986-03-13 1987-03-13 Method of assay of inhibin Ceased AU599373B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH501986 1986-03-13
AUPH5019 1986-03-13

Publications (2)

Publication Number Publication Date
AU7203687A true AU7203687A (en) 1987-10-09
AU599373B2 AU599373B2 (en) 1990-07-19

Family

ID=3771514

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72036/87A Ceased AU599373B2 (en) 1986-03-13 1987-03-13 Method of assay of inhibin

Country Status (8)

Country Link
EP (1) EP0260306A4 (en)
JP (1) JPS63503086A (en)
AU (1) AU599373B2 (en)
CA (1) CA1307736C (en)
IL (1) IL81889A0 (en)
NZ (1) NZ219609A (en)
WO (1) WO1987005702A1 (en)
ZA (1) ZA871844B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942220A (en) * 1990-03-16 1999-08-24 Chiron Corporation Inhibitor of cytokine activity and applications thereof
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9316369D0 (en) * 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method
GB9410345D0 (en) * 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
GB9614615D0 (en) * 1996-07-11 1996-09-04 Isis Innovation Diagnosis of pre-eclampsia
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
AU779576B2 (en) 1999-02-25 2005-01-27 Auckland Uniservices Limited Diagnosis and therapy of premature ovarian failure
CN1747747B (en) 2003-01-06 2012-09-05 安吉奥开米公司 Aprotinin and analogs as carriers across the blood-brain barrier
US20070031835A1 (en) * 2003-03-28 2007-02-08 Risbridger Gail P Diagnosis of advanced cancer
CN101160403B (en) 2005-02-18 2014-08-13 安吉奥开米公司 Molecules for transporting a compound across the blood-brain barrier
WO2007009229A1 (en) 2005-07-15 2007-01-25 Angiochem Inc. Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
MX2011005963A (en) 2008-12-05 2011-09-01 Angiochem Inc Conjugates of neurotensin or neurotensin analogs and uses thereof.
CN102300987A (en) 2008-12-17 2011-12-28 安吉奥开米公司 Membrane Type-1 Matrix Metalloprotein Inhibitors And Uses Thereof
EP2421562B1 (en) 2009-04-20 2019-03-13 Angiochem Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
CN102596993A (en) 2009-07-02 2012-07-18 安吉奥开米公司 Multimeric peptide conjugates and uses thereof
US10980892B2 (en) 2015-06-15 2021-04-20 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
WO1986006076A1 (en) * 1985-04-18 1986-10-23 Biotechnology Australia Pty. Ltd. Recombinant inhibin
US4624944A (en) * 1985-06-14 1986-11-25 The Regents Of The University Of California Human seminal alpha-inhibins
US4740587A (en) * 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
NZ217727A (en) * 1985-10-03 1990-05-28 Genentech Inc Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it

Also Published As

Publication number Publication date
EP0260306A4 (en) 1990-09-26
JPS63503086A (en) 1988-11-10
ZA871844B (en) 1988-05-25
IL81889A0 (en) 1987-10-20
CA1307736C (en) 1992-09-22
WO1987005702A1 (en) 1987-09-24
NZ219609A (en) 1990-09-26
AU599373B2 (en) 1990-07-19
EP0260306A1 (en) 1988-03-23

Similar Documents

Publication Publication Date Title
AU4472685A (en) Methods of assay
AU7494187A (en) Assay method of immune reaction and apparatus
AU7203687A (en) Method of assay of inhibin
AU7462087A (en) Method of chain combination
AU581362B2 (en) Aircraftloader and method of assembly
AU4043389A (en) Method of assay
AU587530B2 (en) Method of spin-welding
AU1043788A (en) Method of identifying unknown organisms
AU7405987A (en) Methods of immunoassay
AU625455B2 (en) Simple method for immunological assay
AU582303B2 (en) Method of curve approximation
IL90396A0 (en) Method of assay
AU585161B2 (en) Micropropogation process
AU5548986A (en) Microtiter-surface-flocculation assay for antigen or antibodyscreening
AU8069787A (en) Insect-proofing method
AU2409088A (en) Enzyme assay method
AU3953885A (en) Methods of assay
AU7480187A (en) 16alpha-methylation process
AU1619688A (en) Method of construction
AU6522490A (en) Assay method
AU603846B2 (en) Method for preparation of mercaptobenzoates
AU2133288A (en) Method of obtaining butene-1
AU6961087A (en) Novel method
AU4712585A (en) Methods of assay
AU574646B2 (en) Enzyme assay method